- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02121730
Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions (FRISC)
Identification of Key Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais, Normandy and Picardy Regions
Kidney transplantation is now the treatment of choice for end-stage renal disease (ESRD). Between 2800 and 3000 kidney transplants are performed each year in France and more than 33 000 patients are living with a functioning graft.
Preventing allograft rejection requires the use of immunosuppressive therapy, the intensity decreases as the distance from the day of transplantation. Unfortunately, treatment favors certain complications, including infectious and neoplastic. These represent a major cause of mortality in these patients. If the frequency of skin cancer is greatly increased in this population, that of solid tumors remains a concern. Approximately 20% of patients develop cancer after 10 years of graft , half non- skin cancers, the main risk factor is immunosuppressive therapy .
The aim of the study is to evaluate, in a large population of patients treated in 4 regions ( the Nord-Pas de Calais, the Upper and Lower Normandy and Picardy) risk factors (in particular the nature of the immunosuppressive treatment) of developing a neoplastic complication, skin cancers and solid tumors, after renal transplantation.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
A retrospective analysis of the previous 10 years, from 2002 to 2011 will be conducted. This study will better understand the epidemiology of these complications but also allow to identify risk factors associated, including demographic, environmental and related to immunosuppressive therapy.
Thereafter, we hope to implement preventive measures or prospective studies, allowing us to reduce the prevalence of this complication.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Luoghi di studio
-
-
-
Amiens, Francia, 80000
- Reclutamento
- CHU Amiens
-
Investigatore principale:
- Gabriel Choukroun, MD, PhD
-
Caen, Francia, 14000
- Non ancora reclutamento
- CHU CAEN
-
Contatto:
- Bruno Hurault de Ligny, MD, PhD
- Email: huraultdeligny-b@chu-caen.fr
-
Investigatore principale:
- Bruno Bruno Hurault de Ligny, MD, PhD
-
Lille, Francia, 59000
- Non ancora reclutamento
- Chru Lille
-
Contatto:
- Marc HAZZAN, MD, PhD
- Email: m-hazzan@chru-lille.fr
-
Investigatore principale:
- Marc Hazzan, MD, PhD
-
Rouen, Francia, 76000
- Non ancora reclutamento
- CHU Rouen
-
Contatto:
- Michel GODIN, MD, PhD
- Email: michel.godin@chu-rouen.fr
-
Investigatore principale:
- Michel Godin, MD, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- All adult renal transplant patients in the 4 centers of interregion North - West
- Patients transplanted during the period from 1 January 2002 and 31 December 2011
- Patients recipients of first, second or third renal transplantation
- Patients transplant recipients from a living or deceased donor whatever the immunological risk
- Eligible patients will be included after being informed by their doctor and after accepting their data to be processed in the framework of this study
- Patient with a health insurance coverage
Exclusion Criteria:
- Patients transplanted as child
- Patients transplanted before 1 January 2002
- Patients followed in the interregion but transplanted in another center
- Patients recipients of a double transplant (two kidneys or kidney plus other organ)
- Patients that do not accept their medical data to be included in the database
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
---|
Kidney Transplantation
Patients who had undergone renal transplantation for 10 years in the interregion Northwest (Normandy, Picardy and Nord-Pas de Calais).
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Association between neoplastic complications and cancers
Lasso di tempo: 10 years
|
Correlation, in a population of renal transplant patients followed in interregion Northwest, of the association of neoplastic complications after renal transplantation, skin cancers and solid tumors outside the non-Hodgkin's lymphoma and the terms of immunosuppressive treatment used
|
10 years
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Risk factors
Lasso di tempo: 10 years
|
Identify the main risk factors for developing cancer after transplantation, besides immunosuppressive therapy
|
10 years
|
Incidence
Lasso di tempo: 10 years
|
Evaluate the incidence of neoplastic complications after renal transplantation in interregion Northwest
|
10 years
|
Typology of cancers
Lasso di tempo: 10 years
|
Assess the distribution and respective frequency of different types of cancer, skin and solid tumors in this group of patients
|
10 years
|
Survival prognosis
Lasso di tempo: 10 years
|
Establish the prognosis and survival of transplanted patients with a diagnosis of cancer after transplantation
|
10 years
|
Survival factors
Lasso di tempo: 10 years
|
Analyze the factors associated with the survival of transplanted patients who developed cancer after transplantation
|
10 years
|
Graft survival
Lasso di tempo: 10 years
|
Evaluate graft survival in the group of patients who develop post- transplantation cancer , especially after cancer diagnosis
|
10 years
|
Rejection number
Lasso di tempo: 10 years
|
Determine the number of cellular acute rejection and humoral rejections in patients who developed cancer and those free from this complication and analyze the prevalence of releases in the period following the diagnosis of cancer
|
10 years
|
Renal function after cancer
Lasso di tempo: 10 years
|
To analyze the evolution of renal function after cancer diagnosis
|
10 years
|
Cancer management
Lasso di tempo: 10 years
|
Analyze the management of these cancers, in particular as regards the strategy of immunosuppressive therapy after cancer diagnosis
|
10 years
|
Collaboratori e investigatori
Investigatori
- Direttore dello studio: Gabriel Choukroun, MD, PhD, CHU Amiens
- Cattedra di studio: Marc Hazzan, MD, PhD, Chru Lille
- Cattedra di studio: Bruno Hurault de Ligny, MD, PhD, CHU CAEN
- Cattedra di studio: Michel Godin, MD, PhD, CHU Rouen
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PI2012_843_0006
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Cancro del rene
-
Sorbonne UniversityAalborg UniversityReclutamentoEcografia Point of CareFrancia
-
Asociacion Española Primera en SaludIntensive Care Unit Pasteur HospitalCompletatoEcografia Point of CareUruguay
-
Aga Khan UniversityThe Hospital for Sick Children; Grand Challenges CanadaSconosciuto
-
Aalborg UniversityThe General Practice Foundation in Denmark (grant number A3495); The Novo Nordisk... e altri collaboratoriReclutamento
-
Kecioren Education and Training HospitalCompletato
-
Hôpital Européen MarseilleCompletatoTerapia intensiva | Elettroliti | Sistemi Point of CareFrancia
-
Weill Medical College of Cornell UniversityIthaca CollegeNon ancora reclutamentoTransitioning Voice of Transgender e Gender Diverse PeopleStati Uniti
-
Queens College, The City University of New YorkReclutamentoPubblicazione di articoli sottoposti all'American Journal of Public HealthStati Uniti
-
Research Unit Of General Practice, CopenhagenUniversity of Copenhagen; Region Capital Denmark; The Copenhagen General Practice... e altri collaboratoriCompletato
-
Tanta UniversitySconosciutoDiametro della guaina del nervo ottico | Ecografia Point of CareEgitto